Marin H. Kollef

61.1k total citations · 16 hit papers
550 papers, 40.9k citations indexed

About

Marin H. Kollef is a scholar working on Critical Care and Intensive Care Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marin H. Kollef has authored 550 papers receiving a total of 40.9k indexed citations (citations by other indexed papers that have themselves been cited), including 305 papers in Critical Care and Intensive Care Medicine, 273 papers in Epidemiology and 126 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marin H. Kollef's work include Nosocomial Infections in ICU (268 papers), Pneumonia and Respiratory Infections (143 papers) and Antibiotic Use and Resistance (112 papers). Marin H. Kollef is often cited by papers focused on Nosocomial Infections in ICU (268 papers), Pneumonia and Respiratory Infections (143 papers) and Antibiotic Use and Resistance (112 papers). Marin H. Kollef collaborates with scholars based in United States, Spain and France. Marin H. Kollef's co-authors include Victoria J. Fraser, Scott T. Micek, Andrew F. Shorr, Suzanne M. Ward, Glenda Sherman, Marya D. Zilberberg, Emad Ibrahim, Richard G. Wunderink, Jordi Rello and Donna Prentice and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marin H. Kollef

529 papers receiving 39.3k citations

Hit Papers

The Influence of Inadequate Antimicrobial Treatment of Bl... 1993 2026 2004 2015 2000 1999 2005 2002 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
    2000 1.3k citations Victoria J. Fraser, Marin H. Kollef et al. CHEST Journal profile →
  2. Inadequate Antimicrobial Treatment of Infections
    1999 1.3k citations Marin H. Kollef, Victoria J. Fraser et al. CHEST Journal profile →
  3. Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
    2005 985 citations Victoria J. Fraser, Marin H. Kollef et al. Antimicrobial Agents and Chemotherapy profile →
  4. Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
    2002 959 citations Marin H. Kollef et al. CHEST Journal profile →
  5. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
    2017 802 citations Marin H. Kollef et al. profile →
  6. Epidemiology and Outcomes of Health-care–Associated Pneumonia
    2005 721 citations Marin H. Kollef, Andrew F. Shorr et al. CHEST Journal profile →
  7. The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
    2007 699 citations Marin H. Kollef et al. profile →
  8. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation
    1999 695 citations William D. Shannon, Marin H. Kollef et al. Critical Care Medicine profile →
  9. Clinical Importance of Delays in the Initiation of Appropriate Antibiotic Treatment for Ventilator-Associated Pneumonia
    2002 690 citations Victoria J. Fraser, Marin H. Kollef et al. CHEST Journal profile →
  10. The Use of Continuous IV Sedation Is Associated With Prolongation of Mechanical Ventilation
    1998 627 citations Marin H. Kollef et al. CHEST Journal profile →
  11. Ventilator-Associated Pneumonia
    1993 558 citations Marin H. Kollef profile →
  12. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation
    1997 525 citations Marin H. Kollef, William D. Shannon et al. Critical Care Medicine profile →
  13. The Acute Respiratory Distress Syndrome
    1995 412 citations Marin H. Kollef et al. profile →
  14. The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
    2021 403 citations Marin H. Kollef et al. profile →
  15. Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
    2012 402 citations Marin H. Kollef, Andrew F. Shorr et al. profile →
  16. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
    2020 319 citations Marin H. Kollef, Andrew F. Shorr et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marin H. Kollef United States 106 18.4k 18.0k 8.7k 8.4k 7.0k 550 40.9k
Jordi Rello Spain 94 11.2k 0.6× 14.7k 0.8× 5.1k 0.6× 6.2k 0.7× 4.3k 0.6× 568 27.2k
Antoní Torres Spain 87 12.6k 0.7× 20.8k 1.2× 4.0k 0.5× 10.8k 1.3× 3.7k 0.5× 669 34.1k
Richard G. Wunderink United States 73 6.9k 0.4× 12.9k 0.7× 4.2k 0.5× 4.9k 0.6× 4.2k 0.6× 321 23.7k
Jean Chastre France 85 12.3k 0.7× 11.3k 0.6× 2.0k 0.2× 8.1k 1.0× 3.8k 0.5× 267 25.1k
Teresa Horan United States 47 6.8k 0.4× 9.5k 0.5× 7.1k 0.8× 3.7k 0.4× 3.5k 0.5× 77 35.6k
Robert A. Weinstein United States 78 4.0k 0.2× 7.3k 0.4× 9.4k 1.1× 2.6k 0.3× 6.4k 0.9× 349 27.9k
Victoria J. Fraser United States 80 6.2k 0.3× 8.7k 0.5× 7.3k 0.8× 2.5k 0.3× 2.2k 0.3× 331 25.1k
William R. Jarvis United States 88 5.1k 0.3× 10.7k 0.6× 12.9k 1.5× 4.4k 0.5× 2.5k 0.4× 482 41.9k
Marc J. M. Bonten Netherlands 81 4.4k 0.2× 8.6k 0.5× 8.7k 1.0× 2.5k 0.3× 4.8k 0.7× 558 24.7k
Michael S. Niederman United States 65 7.6k 0.4× 14.6k 0.8× 2.5k 0.3× 5.0k 0.6× 2.8k 0.4× 256 21.1k

Countries citing papers authored by Marin H. Kollef

Since Specialization
Citations

This map shows the geographic impact of Marin H. Kollef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marin H. Kollef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marin H. Kollef more than expected).

Fields of papers citing papers by Marin H. Kollef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marin H. Kollef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marin H. Kollef. The network helps show where Marin H. Kollef may publish in the future.

Co-authorship network of co-authors of Marin H. Kollef

This figure shows the co-authorship network connecting the top 25 collaborators of Marin H. Kollef. A scholar is included among the top collaborators of Marin H. Kollef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marin H. Kollef. Marin H. Kollef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillamet, Cristina Vazquez, et al.. (2024). Performance of Risk Models for Antimicrobial Resistance in Adult Patients With Sepsis. JAMA Network Open. 7(11). e2443658–e2443658.
2.
Cornely, Oliver A., George R. Thompson, Àlex Soriano, et al.. (2024). P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data. JAC-Antimicrobial Resistance. 6(Supplement_1). 1 indexed citations
3.
4.
Kollef, Marin H., et al.. (2018). Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures. Respiratory Care. 63(5). 495–501. 28 indexed citations
5.
Burnham, Jason P., Margaret A. Olsen, Dustin Stwalley, et al.. (2018). Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections. Open Forum Infectious Diseases. 5(3). ofy026–ofy026. 69 indexed citations
6.
7.
Fisher, Kristen, et al.. (2017). A Prospective One-Year Microbiologic Survey of Combined Pneumonia and Respiratory Failure. Surgical Infections. 18(7). 827–833. 9 indexed citations
8.
9.
Dimοpoulos, George, Marin H. Kollef, Dimitrios K. Matthaiou, & Βruce Montgomery. (2014). Aerolized antibiotics for the treatment of Ventilator Associated Pneumonia: A new era!. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Zilberberg, Marya D., Andrew F. Shorr, Scott T. Micek, & Marin H. Kollef. (2014). Clostridium difficile Recurrence Is a Strong Predictor of 30-Day Rehospitalization Among Patients in Intensive Care. Infection Control and Hospital Epidemiology. 36(3). 273–279. 11 indexed citations
11.
Brown, Sarah M., Karl Hock, Mitchell G. Scott, et al.. (2011). Diagnostic Utility of Plasma Procalcitonin for Nosocomial Pneumonia in the Intensive Care Unit Setting. Respiratory Care. 56(4). 412–419. 15 indexed citations
12.
Micek, Scott T., Emily Welch, Junaid Habib Khan, et al.. (2010). Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis. Antimicrobial Agents and Chemotherapy. 54(5). 1742–1748. 181 indexed citations
13.
Morrow, Lee E., Marin H. Kollef, & Thomas B. Casale. (2010). Probiotic Prophylaxis of Ventilator-associated Pneumonia: A Blinded, Randomized, Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 182(8). 1058–1064. 248 indexed citations
14.
Kollef, Marin H., et al.. (2010). The Resuscitation Package in Sepsis. Current Infectious Disease Reports. 12(5). 368–373. 1 indexed citations
15.
Micek, Scott T., Victor Pham, Joshua A. Doherty, et al.. (2010). Bacteremia Increases the Risk of Death among Patients with Soft-Tissue Infections. Surgical Infections. 11(2). 169–176. 11 indexed citations
16.
Kollef, Marin H.. (2010). Prevention of Nosocomial Pneumonia in the Intensive Care Unit: Beyond the Use of Bundles. Surgical Infections. 12(3). 211–220. 15 indexed citations
17.
Kollef, Marin H., et al.. (2009). Antimicrobial Stewardship in the Intensive Care Unit. American Journal of Respiratory and Critical Care Medicine. 179(6). 434–438. 78 indexed citations
18.
19.
Kollef, Marin H.. (2006). The Intensive Care Unit as a Research Laboratory: Developing Strategies to Prevent Antimicrobial Resistance. Surgical Infections. 7(2). 85–99. 1 indexed citations
20.
Yusen, Roger D. & Marin H. Kollef. (1995). Acute Respiratory Failure Due to Extramedullary Hematopoiesis. CHEST Journal. 108(4). 1170–1172. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordi Rello Breakdown of academic impact, for papers by Antoní Torres Breakdown of academic impact, for papers by Richard G. Wunderink Breakdown of academic impact, for papers by Jean Chastre Breakdown of academic impact, for papers by Teresa Horan Breakdown of academic impact, for papers by Robert A. Weinstein Breakdown of academic impact, for papers by Victoria J. Fraser Breakdown of academic impact, for papers by William R. Jarvis Breakdown of academic impact, for papers by Marc J. M. Bonten Breakdown of academic impact, for papers by Michael S. Niederman
Rankless by CCL
2026